Invivyd, Inc. SEC filings IVVD

Invivyd, Inc. has 448 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (other events). The company's fiscal year ends on December 31.

Invivyd, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Sep 29, 2026 Sep 29, 2026
8-K Current report
Officer or director change, Other events
Sep 1, 2026 Aug 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Listing notice
Jul 24, 2026 Jul 23, 2026
8-K Current report
Other events
Jul 6, 2026 Jul 6, 2026
8-K Current report
Shareholder vote results
May 19, 2026 May 19, 2026
8-K Current report
Results of operations, Other events
May 14, 2026 May 14, 2026
8-K Current report
Other events
Apr 9, 2026 Apr 9, 2026
8-K Current report
Results of operations, Other events
Mar 5, 2026 Mar 5, 2026
8-K Current report
Results of operations, Other events
Jan 8, 2026 Jan 8, 2026
8-K Current report
Other events
Dec 23, 2025 Dec 23, 2025
8-K Current report
Other events
Nov 24, 2025 Nov 24, 2025
8-K Current report
Material agreement, Other events
Nov 19, 2025 Nov 17, 2025
8-K Current report
Results of operations, Other events
Nov 6, 2025 Nov 6, 2025
8-K Current report
Other events
Oct 30, 2025 Oct 30, 2025
8-K Current report
Other events
Oct 6, 2025 Oct 6, 2025
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Sep 24, 2025 Sep 22, 2025
8-K Current report
Material agreement, Other events
Aug 22, 2025 Aug 20, 2025
8-K Current report
Results of operations, Other events
Aug 14, 2025 Aug 14, 2025
8-K Current report
Other events
Jul 2, 2025 Jul 2, 2025
8-K Current report
Other events
Jun 26, 2025 Jun 26, 2025
8-K Current report
Shareholder vote results
May 20, 2025 May 20, 2025
8-K Current report
Results of operations, Other events
May 15, 2025 May 15, 2025
8-K Current report
Other events
May 12, 2025 May 12, 2025
8-K Current report
Listing notice
Apr 25, 2025 Apr 21, 2025
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Apr 21, 2025 Apr 18, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 26, 2025 Mar 22, 2025
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
8-K Current report
Other events
Mar 5, 2025 Mar 5, 2025
8-K Current report
Other events
Feb 24, 2025 Feb 21, 2025
8-K Current report
Results of operations, Other events
Feb 3, 2025 Feb 3, 2025
8-K Current report
Other events
Jan 27, 2025 Jan 27, 2025
8-K Current report
Other events
Jan 10, 2025 Jan 10, 2025
8-K Current report
Listing notice
Dec 27, 2024 Dec 27, 2024
8-K Current report
Officer or director change
Dec 2, 2024 Nov 27, 2024
8-K Current report
Results of operations, Other events
Nov 14, 2024 Nov 14, 2024
8-K Current report
Results of operations, Other events
Oct 29, 2024 Oct 29, 2024
8-K Current report
Other events
Sep 23, 2024 Sep 23, 2024
8-K Current report
Other events
Sep 6, 2024 Sep 6, 2024
8-K Current report
Other events
Sep 4, 2024 Sep 4, 2024
8-K Current report
Other events
Sep 3, 2024 Sep 3, 2024
8-K Current report
Other events
Aug 27, 2024 Aug 27, 2024
8-K Current report
Results of operations, Other events
Aug 14, 2024 Aug 14, 2024
8-K Current report
Other events
Jun 14, 2024 Jun 14, 2024
8-K Current report
Officer or director change, Other events
May 31, 2024 May 30, 2024
8-K Current report
Shareholder vote results, Regulation FD disclosure
May 22, 2024 May 21, 2024
8-K Current report
Results of operations, Other events
May 9, 2024 May 9, 2024
8-K Current report
Other events
May 7, 2024 May 7, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 12, 2024 Apr 11, 2024
8-K Current report
Other events
Apr 4, 2024 Apr 4, 2024
8-K Current report
Results of operations
Mar 28, 2024 Mar 28, 2024
8-K Current report
Results of operations, Other events
Mar 25, 2024 Mar 22, 2024
8-K Current report
Officer or director change, Other events
Feb 9, 2024 Feb 5, 2024
8-K Current report
Other events
Jan 8, 2024 Jan 8, 2024
8-K Current report
Other events
Jan 3, 2024 Jan 3, 2024
8-K Current report
Material agreement
Dec 22, 2023 Dec 22, 2023
8-K Current report
Other events
Dec 18, 2023 Dec 18, 2023
8-K Current report
Results of operations, Other events
Nov 9, 2023 Nov 9, 2023
8-K Current report
Other events
Sep 11, 2023 Sep 11, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 5, 2023 Sep 5, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 27, 2023 Jul 25, 2023
8-K Current report
Other events
Jun 29, 2023 Jun 29, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 25, 2023 May 23, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Officer or director change, Other events
May 2, 2023 Apr 26, 2023
8-K Current report
Results of operations
Mar 23, 2023 Mar 23, 2023
8-K Current report
Other events
Mar 6, 2023 Mar 6, 2023
8-K Current report
Other events
Jan 9, 2023 Jan 9, 2023
8-K Current report
Officer or director change, Other events
Dec 6, 2022 Dec 6, 2022
8-K Current report
Material agreement, Unregistered share sale, Other events
Nov 17, 2022 Nov 15, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 24, 2022 Oct 20, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 13, 2022 Oct 11, 2022
8-K Current report
Bylaw or fiscal year change
Sep 13, 2022 Sep 9, 2022
8-K Current report
Other events
Sep 12, 2022 Sep 12, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
8-K Current report
Officer or director change, Other events
Jul 5, 2022 Jul 1, 2022
8-K Current report
Officer or director change
Jun 30, 2022 Jun 24, 2022
8-K Current report
Shareholder vote results
Jun 22, 2022 Jun 22, 2022
8-K Current report
Officer or director change
Jun 21, 2022 Jun 17, 2022
8-K Current report
Other events
May 19, 2022 May 19, 2022
8-K Current report
Results of operations
May 13, 2022 May 13, 2022
8-K Current report
Results of operations
Mar 30, 2022 Mar 30, 2022
8-K Current report
Officer or director change, Other events
Mar 21, 2022 Mar 18, 2022
8-K/A Amended current report
Officer or director change
Mar 21, 2022 Feb 23, 2022
8-K Current report
Officer or director change
Mar 1, 2022 Feb 23, 2022
8-K Current report
Officer or director change, Other events
Feb 23, 2022 Feb 23, 2022
8-K Current report
Other events
Feb 22, 2022 Feb 18, 2022
8-K Current report
Officer or director change
Feb 18, 2022 Feb 14, 2022
8-K Current report
Regulation FD disclosure, Other events
Jan 13, 2022 Jan 12, 2022
8-K Current report
Regulation FD disclosure
Dec 14, 2021 Dec 14, 2021
8-K Current report
Regulation FD disclosure
Nov 29, 2021 Nov 29, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 22, 2021 Nov 19, 2021
8-K Current report
Regulation FD disclosure
Nov 16, 2021 Nov 16, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
8-K Current report
Other events
Oct 19, 2021 Oct 19, 2021
8-K Current report
Other events
Sep 29, 2021 Sep 29, 2021
8-K Current report
Results of operations
Sep 20, 2021 Sep 20, 2021
8-K Current report
Other events
Sep 10, 2021 Sep 10, 2021
8-K Current report
Bylaw or fiscal year change
Aug 10, 2021 Aug 10, 2021

Showing 101 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
IVVD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Haven, CT
SEC filer status
, Emerging growth company
SEC CIK
1832038
Former names
Adagio Therapeutics, Inc. (until Sep 12, 2022)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.